HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emad Rakha Selected Research

Hormones (Hormone)

5/2024Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study.
1/2024Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study.
1/2022Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.
5/2010Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
6/2009Basal-like breast carcinoma: from expression profiling to routine practice.
9/2005High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emad Rakha Research Topics

Disease

31Breast Neoplasms (Breast Cancer)
05/2024 - 09/2005
21Neoplasms (Cancer)
03/2024 - 06/2009
8Triple Negative Breast Neoplasms
12/2023 - 10/2017
5Neoplasm Metastasis (Metastasis)
11/2023 - 04/2018
4Carcinoma (Carcinomatosis)
09/2023 - 11/2012
3Prostatic Neoplasms (Prostate Cancer)
01/2023 - 01/2022
2Disease Progression
03/2024 - 01/2022
2Noninfiltrating Intraductal Carcinoma (DCIS)
09/2023 - 02/2020
2Papillary Carcinoma
09/2023 - 08/2020
1Papillary Thyroid Cancer
09/2023
1Adenomyoepithelioma
10/2021
1Pleomorphic Adenoma
10/2021
1Adenoid Cystic Carcinoma (Cylindroma)
10/2021
1COVID-19
07/2021
1Melanoma (Melanoma, Malignant)
08/2020
1Lymphoma (Lymphomas)
08/2020
1Colorectal Neoplasms (Colorectal Cancer)
08/2020
1Breast Ductal Carcinoma
02/2020
1Disorders of Sex Development (Intersexuality)
08/2017
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
08/2017
1Adenocarcinoma of Lung
09/2015
1Lobular Carcinoma
07/2013
1Confusion (Bewilderment)
07/2013

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
03/2024 - 09/2005
8Phenobarbital (Luminal)FDA Link
12/2023 - 04/2015
6Hormones (Hormone)IBA
05/2024 - 09/2005
6Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2005
6Messenger RNA (mRNA)IBA
09/2023 - 11/2014
4human ERBB2 proteinIBA
03/2024 - 01/2022
3Estrogen ReceptorsIBA
11/2023 - 11/2014
3ErbB Receptors (EGF Receptor)IBA
10/2023 - 05/2010
3RNA (Ribonucleic Acid)IBA
01/2022 - 09/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 07/2014
2trastuzumab deruxtecanIBA
03/2024 - 08/2023
2Progesterone Receptors (Progesterone Receptor)IBA
01/2023 - 01/2018
2AndrogensIBA
01/2022 - 08/2017
2Trastuzumab (Herceptin)FDA Link
11/2019 - 01/2018
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
11/2014 - 07/2014
2Keratins (Keratin)IBA
05/2013 - 05/2010
1Immunoconjugates (Immunoconjugate)IBA
03/2024
1Eosine Yellowish-(YS) (Eosin)IBA
11/2023
1Indicators and Reagents (Reagents)IBA
11/2023
1DenosumabFDA Link
11/2023
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
11/2023
1RANK LigandIBA
11/2023
1CollagenIBA
09/2023
1Capsules (Microcapsules)IBA
09/2023
1erucylphosphocholineIBA
09/2023
1EPTCIBA
09/2023
1Lysine (L-Lysine)FDA Link
01/2023
1Androgen Receptors (Androgen Receptor)IBA
01/2023
1ezrinIBA
01/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2022
1MethyltransferasesIBA
01/2022
16-methyladenineIBA
01/2022
1methylamphotericin B (AME)IBA
10/2021
1VaccinesIBA
07/2021
1SuspensionsIBA
07/2021
1MART-1 AntigenIBA
08/2020
1CathepsinsIBA
02/2020
1Dopamine and cAMP-Regulated Phosphoprotein 32IBA
11/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1AntigensIBA
01/2019
1InterleukinsIBA
04/2018
1Interleukin-6 (Interleukin 6)IBA
04/2018
1CytokinesIBA
04/2018
1Interleukin-10 (Interleukin 10)IBA
04/2018
1ErbB-2 ReceptorIBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1TamoxifenFDA LinkGeneric
01/2018
1Checkpoint Kinase 1IBA
01/2018
1Lapatinib (GW572016)FDA Link
01/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2018
1A-Form DNA (A-DNA)IBA
01/2018
1Jagged-1 ProteinIBA
01/2018
1Tacrolimus Binding Proteins (FKBP)IBA
05/2015
1Peptides (Polypeptides)IBA
05/2015
1PPAR gammaIBA
04/2015
13- amino- 6- (4- (methylsulfonyl)phenyl)- N- phenylpyrazine- 2- carboxamideIBA
03/2015
1Serine (L-Serine)FDA Link
03/2015
1Methotrexate (Mexate)FDA LinkGeneric
11/2014
1AnthracyclinesIBA
11/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014
1Ataxia Telangiectasia Mutated ProteinsIBA
11/2014
1DNA-Activated Protein KinaseIBA
07/2014
1AntibodiesIBA
07/2013
1CateninsIBA
07/2013
1Cadherins (E-Cadherin)IBA
07/2013
1Epidermal Growth Factor (EGF)IBA
05/2010

Therapy/Procedure

12Therapeutics
05/2024 - 05/2010
5Drug Therapy (Chemotherapy)
11/2023 - 11/2014
3Adjuvant Chemotherapy
11/2023 - 11/2014
2Radiotherapy
01/2018 - 01/2018
1Braces
11/2023
1Lymph Node Excision (Lymph Node Dissection)
03/2022
1Castration
01/2022
1Precision Medicine
10/2017
1Segmental Mastectomy (Lumpectomy)
10/2014
1Hysterectomy
11/2012
1Contraindications
11/2012